Want to join the conversation?
Andrew Buscaglia of Credit Suisse asks about volume growth expectations. CEO Donald Slager said that $RSG had a strong volume growth in 2Q16. The company had mild winter compared with very tough winter in the prior year. Volume growth is expected to be 1% for the year, he added.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?